Literature DB >> 1298376

The use of microdialysis for the determination of plasma protein binding of drugs.

S Sarre1, K Van Belle, I Smolders, G Krieken, Y Michotte.   

Abstract

Microdialysis sampling was used for the determination of the protein binding and the free therapeutic drug concentration of drugs in plasma in vitro. Several drugs with varying extent of protein binding and for which the plasma monitoring is important were studied. To mimic the in vivo situation, an artificial blood vessel was constructed and filled with spiked plasma circulating at the flow rate of human blood at 37 degrees C. The microdialysis probe (16 mm membrane length, 20000 MW cut off) was placed in the vessel and perfused with 0.9% NaCl at 5 microliters min-1. Dialysates were collected every 10 min and were analysed by reversed-phase LC with UV detection. The free concentration of the drug was calculated by correcting the concentration in the dialysate for the recovery of the probe, which was also determined in the artificial blood vessel after the experiment. The data confirm that microdialysis is a valid alternative technique for the determination of protein binding or free therapeutic plasma concentration of drugs on a comparative basis. Reference to literature values indicates that the results of the proposed method correspond reasonably well with accepted values.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1298376     DOI: 10.1016/0731-7085(91)80073-i

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  8 in total

Review 1.  Application of microdialysis in pharmacokinetic studies.

Authors:  W F Elmquist; R J Sawchuk
Journal:  Pharm Res       Date:  1997-03       Impact factor: 4.200

Review 2.  Pharmacokinetic and metabolism studies using microdialysis sampling.

Authors:  D K Hansen; M I Davies; S M Lunte; C E Lunte
Journal:  J Pharm Sci       Date:  1999-01       Impact factor: 3.534

3.  Quantitative microdialysis for studying the in vivo L-DOPA kinetics in blood and skeletal muscle of the dog.

Authors:  S Sarre; D Deleu; K Van Belle; G Ebinger; Y Michotte
Journal:  Pharm Res       Date:  1995-05       Impact factor: 4.200

Review 4.  Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.

Authors:  Parag Aggarwal; Jennifer B Hall; Christopher B McLeland; Marina A Dobrovolskaia; Scott E McNeil
Journal:  Adv Drug Deliv Rev       Date:  2009-04-17       Impact factor: 15.470

5.  CE-LIF method for the separation of anthracyclines: application to protein binding analysis in plasma using ultrafiltration.

Authors:  Gillian Whitaker; Amy Lillquist; Stephanie A Pasas; Robert O'Connor; Fiona Regan; Craig E Lunte; Malcolm R Smyth
Journal:  J Sep Sci       Date:  2008-06       Impact factor: 3.645

6.  Theophylline kinetics in peripheral tissues in vivo in humans.

Authors:  M Müller; B v Osten; R Schmid; E Piegler; I Gerngross; H Buchegger; H G Eichler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-10       Impact factor: 3.000

7.  Microdialysis: an alternative for in vitro and in vivo protein binding studies.

Authors:  A Le Quellec; S Dupin; A E Tufenkji; P Genissel; G Houin
Journal:  Pharm Res       Date:  1994-06       Impact factor: 4.200

8.  Naphthyridine derived colorimetric and fluorescent turn off sensors for Ni2+ in aqueous media.

Authors:  Abida Ashraf; Muhammad Islam; Muhammad Khalid; Anthony P Davis; Muhammad Tayyeb Ahsan; Muhammad Yaqub; Asad Syed; Abdallah M Elgorban; Ali H Bahkali; Zahid Shafiq
Journal:  Sci Rep       Date:  2021-09-28       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.